Estee Lauder stock dips after cutting profit outlook on weak demand, tariffs

Estee Lauder shares slid over 4% after the company forecast annual profit significantly below Wall Street expectations, citing ongoing demand weakness in the U.S. and China, alongside tariff uncertainty, which is projected to create $100 million in profitability headwinds for fiscal year 2026. The cosmetics giant guided full-year adjusted EPS to a range of $1.90-$2.10, notably short of the $2.21 analyst consensus, with organic net sales growth expected between 0% and 3%. While its fiscal fourth-quarter EPS slightly beat estimates and revenue marginally topped consensus, organic net sales declined 13% across all geographic regions, particularly in Skin Care and Makeup, contributing to a negative market perception despite the CEO's long-term optimism for rebuilding operating profitability.

Analysis

Estee Lauder's shares declined over 4% following the release of a fiscal 2026 profit forecast that fell materially short of Wall Street estimates. The company guided for full-year adjusted EPS between $1.90 and $2.10, below the $2.21 analyst consensus, and projected organic net sales growth of just 0% to 3%. This subdued outlook is attributed to persistent demand weakness in the key U.S. and China markets, alongside a specific warning of a $100 million profitability headwind from tariffs in fiscal 2026. The guidance overshadowed a fiscal fourth quarter that saw a marginal beat on EPS ($0.09 vs. $0.08 est.) and revenue ($3.41B vs. $3.39B est.). However, underlying fundamentals were weak, with a 13% decrease in organic net sales, driven by significant declines in its core Skin Care (-17%) and Makeup (-12%) segments across all geographic regions. While the new CEO expressed confidence in a long-term recovery toward double-digit operating margins, Morgan Stanley analysts noted the weak guidance will likely be perceived negatively given the stock's recent appreciation, even while suggesting the forecast could be a conservative stance.

Key Decisions for Investors

• Given the weak fiscal 2026 guidance and broad-based sales declines, investors should be cautious, as the stock's recent run-up makes it vulnerable to a re-rating based on the significant headwinds in the U.S., China, and travel retail sectors.
• Monitor for tangible signs of a turnaround in the core Skin Care and Makeup segments, as the current guidance implies the recovery timeline may be extended, with tariff uncertainties posing a specific $100 million risk to future profitability.
• Consider whether the new CEO's guidance is overly conservative, which could present a long-term entry point for those with high risk tolerance, but this must be weighed against the severe 13% decline in Q4 organic sales and the lack of immediate growth catalysts.